Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.51 |
| ▸ | LPL | P06858 | 6/20 | 0.51 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | TOP1 | P11387 | 2/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | ROS1 | P08922 | 1/20 | 0.34 |
| ▸ | SMO | Q99835 | 2/20 | 0.33 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29778746 | 1.00 | LIPG (0.51) | LIPGLPLDGAT1TGFBR1TOP1 | |
| SCHEMBL20127858 | 0.93 | LIPG (0.53) | LIPGLPLDGAT1TGFBR1PDGFRB | |
| SCHEMBL21148642 | 0.86 | LIPG (0.47) | LIPGLPLDGAT1TGFBR1PDGFRB | |
| SCHEMBL28781712 | 0.86 | LIPG (0.44) | LIPGLPLDGAT1TGFBR1PDGFRB | |
| SCHEMBL24625916 | 0.84 | LIPG (0.49) | LIPGLPLTGFBR1MAPKAPK2 | |
| SCHEMBL29778719 | 0.84 | LIPG (0.49) | LIPGLPLTGFBR1MAPKAPK2 | |
| SCHEMBL19766317 | 0.84 | LIPG (0.55) | LIPGLPLDGAT1TGFBR1PDGFRB | |
| SCHEMBL23487738 | 0.84 | LIPG (0.67) | LIPGLPLDGAT1TGFBR1PDGFRB | |
| SCHEMBL20598797 | 0.83 | LIPG (0.53) | LIPGLPLDGAT1TGFBR1PDGFRB | |
| SCHEMBL29940665 | 0.83 | LIPG (0.53) | LIPGLPLDGAT1TGFBR1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220142-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220142-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | PYM1, SOD1, SLC39A11 | LIPG 4496/4885LPL 3357/4885DGAT1 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.